These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 22429965
1. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Che Y, Ye F, Xu R, Qing H, Wang X, Yin F, Cui M, Burstein D, Jiang B, Zhang DY. Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965 [Abstract] [Full Text] [Related]
2. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW. Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [Abstract] [Full Text] [Related]
3. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M. Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [Abstract] [Full Text] [Related]
4. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Sirach E, Bureau C, Péron JM, Pradayrol L, Vinel JP, Buscail L, Cordelier P. Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668 [Abstract] [Full Text] [Related]
5. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH. Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716 [Abstract] [Full Text] [Related]
6. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L. Cancer Lett; 2011 Nov 01; 310(1):35-45. PubMed ID: 21763068 [Abstract] [Full Text] [Related]
7. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X. Cancer Res; 2003 Dec 01; 63(23):8323-9. PubMed ID: 14678992 [Abstract] [Full Text] [Related]
8. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Yamaguchi Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Saitou Y, Sugimoto K, Nakano T. Oncol Rep; 2005 Nov 01; 14(5):1311-6. PubMed ID: 16211302 [Abstract] [Full Text] [Related]
9. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Sakemi R, Yano H, Ogasawara S, Akiba J, Nakashima O, Fukahori S, Sata M, Kojiro M. Oncol Rep; 2007 Jul 01; 18(1):65-70. PubMed ID: 17549347 [Abstract] [Full Text] [Related]
10. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest. Datta NS, Chen C, Berry JE, McCauley LK. J Bone Miner Res; 2005 Jun 01; 20(6):1051-64. PubMed ID: 15883646 [Abstract] [Full Text] [Related]
11. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY. Carcinogenesis; 2013 Nov 01; 34(11):2443-51. PubMed ID: 23740840 [Abstract] [Full Text] [Related]
12. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Fujii T, Nomoto S, Koshikawa K, Yatabe Y, Teshigawara O, Mori T, Inoue S, Takeda S, Nakao A. Hepatology; 2006 Jun 01; 43(6):1267-75. PubMed ID: 16628605 [Abstract] [Full Text] [Related]
13. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC. Endocr Relat Cancer; 2007 Jun 01; 14(2):513-29. PubMed ID: 17639064 [Abstract] [Full Text] [Related]
14. [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma]. Xia JT, Li W, Liu YJ, Chen LZ, Wu ZF, Zhang LJ, Wang Q. Zhonghua Gan Zang Bing Za Zhi; 2007 Dec 01; 15(12):918-21. PubMed ID: 18171527 [Abstract] [Full Text] [Related]
15. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation. Won C, Lee CS, Lee JK, Kim TJ, Lee KH, Yang YM, Kim YN, Ye SK, Chung MH. Anticancer Res; 2010 Feb 01; 30(2):481-8. PubMed ID: 20332458 [Abstract] [Full Text] [Related]
16. Silibinin efficacy against human hepatocellular carcinoma. Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R. Clin Cancer Res; 2005 Dec 01; 11(23):8441-8. PubMed ID: 16322307 [Abstract] [Full Text] [Related]
17. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Kang YH, Ji NY, Lee CI, Lee HG, Kim JW, Yeom YI, Kim DG, Yoon SK, Kim JW, Park PJ, Song EY. Amino Acids; 2011 Mar 01; 40(3):1003-13. PubMed ID: 20821239 [Abstract] [Full Text] [Related]
18. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. Chiu CY, Kuo KK, Kuo TL, Lee KT, Cheng KH. Mol Cancer Res; 2012 Mar 01; 10(3):415-27. PubMed ID: 22241220 [Abstract] [Full Text] [Related]